SCHEMBL15480690

SCHEMBL15480690

Cc1nn(-c2ccccc2)c(C)c1-c1scc(NC(=O)c2cccc(F)c2)c1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.49
GRM5 P41594 2/20 0.49
ALDH1A1 P00352 5/20 0.47
LMNA P02545 3/20 0.47
TSHR P16473 3/20 0.44
MAPT P10636 3/20 0.43
KDM4E B2RXH2 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TP53 P04637 1/20 0.42
POLB P06746 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
GAA P10253 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
UBE2M P61081 1/20 0.40
DCUN1D1 Q96GG9 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12756777 0.91 GRM5 (0.51) GRM5ALDH1A1LMNAMAPTKDM4E
SCHEMBL7956142 0.84 SMN1; SMN2 (0.51) SMN1; SMN2GRM5ALDH1A1LMNATSHR
SCHEMBL12831319 0.80 LMNA (0.47) ALDH1A1LMNAMAPTKDM4ENPSR1
SCHEMBL12756794 0.79 HPGD (0.41) SMN1; SMN2ALDH1A1LMNAMAPTKDM4E
SCHEMBL15480685 0.79 MEN1 (0.54) SMN1; SMN2ALDH1A1LMNATSHRMAPT
SCHEMBL12831287 0.77 KDM4E (0.44) SMN1; SMN2ALDH1A1TSHRMAPTKDM4E
SCHEMBL1490346 0.76 MEN1 (0.50) SMN1; SMN2ALDH1A1LMNATSHRMAPT
SCHEMBL12831292 0.76 SMN1; SMN2 (0.46) SMN1; SMN2GRM5ALDH1A1LMNATSHR
SCHEMBL12831298 0.76 SMN1; SMN2 (0.57) SMN1; SMN2GRM5ALDH1A1TSHRMAPT
SCHEMBL1490671 0.75 POLB (0.48) SMN1; SMN2ALDH1A1TSHRMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 SMN1; SMN2 854/4885GRM5 1117/4885ALDH1A1 4409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.